Invesco’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-306,681
| Closed | -$12.9M | – | 3929 |
|
|
2023
Q2 | $12.9M | Sell |
306,681
-37,233
| -11% | -$1.51M | ﹤0.01% | 1622 |
|
|
2023
Q1 | $12.3M | Sell |
343,914
-16,935
| -5% | -$615K | ﹤0.01% | 1634 |
|
|
2022
Q4 | $13.2M | Buy |
360,849
+171,708
| +91% | +$6.79M | ﹤0.01% | 1642 |
|
|
2022
Q3 | $8.92M | Sell |
189,141
-1,214,694
| -87% | -$78.5M | ﹤0.01% | 1875 |
|
|
2022
Q2 | $101M | Buy |
1,403,835
+39,108
| +3% | +$2.86M | 0.03% | 687 |
|
|
2022
Q1 | $110M | Sell |
1,364,727
-25,464
| -2% | -$2.15M | 0.03% | 737 |
|
|
2021
Q4 | $143M | Sell |
1,390,191
-27,746
| -2% | -$2.66M | 0.03% | 653 |
|
|
2021
Q3 | $124M | Sell |
1,417,937
-35,240
| -2% | -$3.19M | 0.03% | 720 |
|
|
2021
Q2 | $130M | Buy |
1,453,177
+39,455
| +3% | +$3.33M | 0.03% | 719 |
|
|
2021
Q1 | $107M | Sell |
1,413,722
-71,701
| -5% | -$5.41M | 0.03% | 767 |
|
|
2020
Q4 | $101M | Buy |
1,485,423
+30,648
| +2% | +$1.91M | 0.03% | 719 |
|
|
2020
Q3 | $77.3M | Sell |
1,454,775
-104,565
| -7% | -$6.23M | 0.03% | 739 |
|
|
2020
Q2 | $90.8M | Buy |
1,559,340
+57,896
| +4% | +$3.11M | 0.03% | 632 |
|
|
2020
Q1 | $59.2M | Sell |
1,501,444
-34,789
| -2% | -$2.03M | 0.02% | 724 |
|
|
2019
Q4 | $91.4M | Buy |
1,536,233
+195,705
| +15% | +$10.5M | 0.03% | 709 |
|
|
2019
Q3 | $71.3M | Sell |
1,340,528
-126,690
| -9% | -$6.5M | 0.02% | 812 |
|
|
2019
Q2 | $75M | Sell |
1,467,218
-94,057
| -6% | -$4.38M | 0.02% | 819 |
|
|
2019
Q1 | $80.8M | Buy |
1,561,275
+921,950
| +144% | +$44.7M | 0.03% | 603 |
|
|
2018
Q4 | $25.2M | Sell |
639,325
-89,974
| -12% | -$4.18M | 0.01% | 1036 |
|
|
2018
Q3 | $37.6M | Sell |
729,299
-197,438
| -21% | -$9.67M | 0.01% | 967 |
|
|
2018
Q2 | $43.5M | Buy |
926,737
+73,454
| +9% | +$3.04M | 0.01% | 893 |
|
|
2018
Q1 | $30.3M | Sell |
853,283
-164,183
| -16% | -$6.43M | 0.01% | 962 |
|
|
2017
Q4 | $44.4M | Sell |
1,017,466
-96,604
| -9% | -$4.51M | 0.02% | 829 |
|
|
2017
Q3 | $58.3M | Sell |
1,114,070
-75,192
| -6% | -$4.19M | 0.02% | 704 |
|
|
2017
Q2 | $69.6M | Sell |
1,189,262
-82,678
| -7% | -$4.3M | 0.02% | 621 |
|
|
2017
Q1 | $58.3M | Buy |
1,271,940
+133,217
| +12% | +$6.63M | 0.02% | 709 |
|
|
2016
Q4 | $59.9M | Buy |
1,138,723
+38,289
| +3% | +$1.85M | 0.02% | 699 |
|
|
2016
Q3 | $49.1M | Buy |
1,100,434
+291,144
| +36% | +$12.6M | 0.02% | 764 |
|
|
2016
Q2 | $30.9M | Buy |
809,290
+675,956
| +507% | +$29.7M | 0.01% | 984 |
|
|
2016
Q1 | $5.5M | Buy |
133,334
+59,602
| +81% | +$2.46M | ﹤0.01% | 1808 |
|
|
2015
Q4 | $3.58M | Buy |
73,732
+52,728
| +251% | +$2.35M | ﹤0.01% | 2147 |
|
|
2015
Q3 | $840K | Sell |
21,004
-5,042
| -19% | -$220K | ﹤0.01% | 3015 |
|
|
2015
Q2 | $1.04M | Buy |
+26,046
| New | +$899K | ﹤0.01% | 3051 |
|
|
2015
Q1 | – | Sell |
-39,965
| Closed | -$1.03M | – | 4086 |
|
|
2014
Q4 | $1.03M | Buy |
+39,965
| New | +$951K | ﹤0.01% | 2957 |
|
Other funds holding SYNH
IA
BTI
CFB
HNB
Invesco's SYNH Position: Q3 2023 in Review
Invesco sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 306,681 shares — an estimated $12.9M sold.
Invesco first reported a position in SYNH in Q4 2014 and held it in 34 quarters. The position peaked at $143M in Q4 2021. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.
- Invesco reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
- Invesco sold 306,681 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $12.9M.
- Invesco first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2014 and held it in 34 quarters.
- Invesco's Syneos Health, Inc. Class A Common Stock position peaked at $143M in Q4 2021.
- 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.
Based on Invesco's 13F filing for Q3 2023, filed 13 Nov 2023.